Categories
WHO calls for urgent action to ban flavoured tobacco and nicotine products
WHO calls for urgent action to ban flavoured tobacco and nicotine products
Oscar Reyes
30 May 2025
Categories
Seventy-eighth World Health Assembly concludes: historic outcomes, consequential highlights
Seventy-eighth World Health Assembly concludes: historic outcomes, consequential highlights
Cristina Mitchell
28 May 2025
Categories
Public health risk of yellow fever remains high in the Americas due to continued occurrence of human cases
Public health risk of yellow fever remains high in the Americas due to continued occurrence of human cases
Cristina Mitchell
27 May 2025
Categories
Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.
Categories
Esophagogastric Tube Recall: BD Issues Correction for Esophagogastric Balloon Tamponade Tubes due to Challenges Removing Plastic Plugs from Rubber Lumen
Esophagogastric Tube Recall: BD Issues Correction for Esophagogastric Balloon Tamponade Tubes due to Challenges Removing Plastic Plugs from Rubber Lumen
Categories
Cetirizine or Levocetirizine: Drug Safety Communication – FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines
The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare but severe itching. These medicines are available in prescription and over-the-counter (OTC) forms. The itching, also called pruritus, has been r
Categories
Chile becomes latest country to join the Alliance for Primary Health Care in the Americas
Chile becomes latest country to join the Alliance for Primary Health Care in the Americas
Cristina Mitchell
22 May 2025
Categories
FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
http://www.fda.gov/news-events/press-announcements/fda-takes-action-address-data-integrity-concerns-two-chinese-third-party-testing-firms
Categories
FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation
FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation
http://www.fda.gov/news-events/press-announcements/fda-and-cbp-seize-nearly-34-million-worth-illegal-e-cigarettes-during-joint-operation
Categories
UMARY- USA.COM Issues Voluntary Nationwide Recall of UNAVY ÁCIDO HIALURÓNICO Caplets and UMOVY ÁCIDO HIALURÓNICO Caplets Due to the Presence of Undeclared Drug Ingredients Dexamethasone, Diclofenac and Omeprazole
FOR IMMEDIATE RELEASE – Date: May 21 2025, Nogales, AZ, UMARY USA is voluntarily recalling all lots of Unavy Ácido HIALURÓNICO (30 caplets/850 mg) and Umovy Ácido HIALURÓNICO (30 caplets/850 mg), to the consumer level. FDA laboratory analysis confirmed that these products are tainted with the drug i
